EU-funded CHAIN project to provide validated cardiac AI documentation in "AI passports
The European Society of Cardiology announced on 6 October 2026 the launch of CHAIN, a 36-month project funded by EU4Health, with 53 partners from 20 countries.
The European Society of Cardiology (ESC) announced on 6 October 2026 the launch of CHAIN — the European Cardiovascular Health Data and AI Network — a 36-month project funded by the EU's EU4Health programme. The consortium comprises 53 partners from 20 European countries, including universities and research centres, hospitals and clinical networks, technology companies, national health ministries and patient organisations, according to the ESC's press release, carried by News-Medical (e9dd0266).
What CHAIN aims to build
The core of the project is a federated ecosystem, aligned with the European Health Data Space (EHDS), for the "safe, efficient and scalable" use of AI and health data in the management of cardiovascular disease and related non-communicable diseases (e9dd0266).
Federated architecture means data remain at each individual institution rather than being pooled into a single central database — the model the EU is increasingly relying on for health data under the newly operative health data space. The press release does not detail how the interoperability will work technically, but places the project explicitly within the EHDS framework.
The project builds on the ESC's EuroHeart registry network, which already collects standardised data on cardiovascular care and outcomes from 18 ESC member countries. It is to serve as the foundation that CHAIN expands into a broader data landscape. The press release also notes that the initiative is connected to the AI Act context, without detailing the relationship.
"AI Passports" and a European tool repository
Validated AI tools are to be made available through a European repository, where each tool will carry an "AI Passport" — documentation of performance, safety and suitability for clinical use (e9dd0266).
The scheme in principle resembles a documentation model for clinical AI: instead of each hospital individually assessing whether a tool works in its setting, the passport is meant to consolidate documentation so that the assessment is transferable across countries and health systems. How strict the validation requirements will be, who will issue the passports, and whether the tools will actually be adopted beyond the project all remain unresolved in the available source material.
Six use cases across 13 countries
CHAIN is to demonstrate the tools through six practical use cases implemented in 13 countries, spanning prevention, early disease detection, clinical decision support and the management of complex cardiovascular conditions (e91a247b).
The individual use cases are not named in the available source material. It is also unclear by what criteria the six were selected, and which countries are involved beyond the stated number.
Policy framing and building blocks
The ESC's press release positions CHAIN as part of the EU's Safe Hearts Plan, in particular its flagship initiative on innovation and the integration of AI and digital technologies in cardiovascular health. The press release also cites synergies with other EU initiatives: EUCAIM, EHDEN, JACARDI and TEHDAS2 (e9dd0266).
Why it matters
According to ESC President Cecilia Linde, one in three deaths in Europe is caused by cardiovascular disease, and the cost of such diseases in the EU — €282 billion annually — exceeds the EU's annual budget (e9dd0266). The figures come from the ESC and have not been independently verified, but they suggest why the EU is prioritising the area: cardiovascular disease is the largest single category of disease burden, and clinical AI has so far been fragmented in local pilots.
CHAIN is therefore not primarily a technology development project, but an infrastructure and standardisation project: can documented, validated AI tools be used across borders without moving the data? That is the premise behind it — not a proven outcome.
Caveats and open questions
The available coverage traces entirely to the ESC's press release. The News-Medical article is secondary reporting of the press release, and the UA.NEWS article is a republication of News-Medical (e91a247b). The two are therefore not independent confirmations of each other, and no primary source from the European Commission or any other party is available in the material examined.
Nor is it stated how much EU4Health is contributing, when the project period formally begins beyond the announcement date, or how the "AI Passport" scheme will be administered and enforced in practice. Whether CHAIN succeeds will depend on details not yet documented: data access in practice, the actual commitment of participating institutions, and whether the validated tools hold up in clinical use.